Z-VAD(OMe)-FMK (Z-Val-Ala-Asp(OMe)-FMK) is a cell-permeable and irreversible pan-caspase inhibitor. Z-VAD(OMe)-FMK is an ubiquitin carboxy-terminal hydrolase L1 (UCHL1) inhibitor. Z-VAD(OMe)-FMK irreversibly modifies UCHL1 by targeting the active site of UCHL1.
Registration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
Synonyms/Alias | 187389-52-2;Z-VAD(OMe)-FMK;Z-Val-Ala-Asp(OMe)-FMK;pan-caspase inhibitor;C22H30FN3O7;ZVAD-FMK;5-Bromo-2 -deoxyuridine;Z-VAD (OMe)-FMK;Z-Val-Ala-Asp(OMe)-fluoromethyl ketone;Z-Val-Ala-Asp(OMe)-CH2F;methyl (3S)-5-fluoro-3-[[(2S)-2-[[(2S)-3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]propanoyl]amino]-4-oxopentanoate;Benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone;z-Val-Ala-Asp(OMe)-fluoromethylketone;methyl (5S,8S,11S)-11-(2-fluoroacetyl)-5-isopropyl-8-methyl-3,6,9-trioxo-1-phenyl-2-oxa-4,7,10-triazatridecan-13-oate;methyl 5-fluoro-3-[2-[[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]propanoylamino]-4-oxopentanoate;Z-Val-Ala-Asp(OCH3)-fluoromethylketone;L-alaninamide, N-[(phenylmethoxy)carbonyl]-L-valyl-N-[(1S)-3-fluoro-1-(2-methoxy-2-oxoethyl)-2-oxopropyl]-;METHYL (3S)-3-[(2S)-2-[(2S)-2-{[(BENZYLOXY)CARBONYL]AMINO}-3-METHYLBUTANAMIDO]PROPANAMIDO]-5-FLUORO-4-OXOPENTANOATE;benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethyl ketone;N-benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone;N-benzyloxycarbonyl-Val-Ala-Asp(O-Me) fluoromethyl ketone;MFCD02684037;Bio2_000471;Z-VAD(OMe)-FMK?;Z-VAD-(OMe)-FMK;Probes1_000501;CBiol_001923;BSPBio_001262;KBioGR_000602;KBioSS_000602;Caspase-1 Inhibitor Z-Val-Ala-DL-Asp-fluoromethylketone;CHEMBL1213366;SCHEMBL15012737;Z-Val-Ala-Asp(OCH3)-CH2F;KBio2_000602;KBio2_003170;KBio2_005738;KBio3_001063;KBio3_001064;DTXSID40420586;CHEBI:137045;Bio1_000209;Bio1_000698;Bio1_001187;Bio2_000951;HMS1362P03;HMS1792P03;HMS1990P03;HMS3403P03;EX-A2192;HB1285;HB1319;Z-L-Val-L-Ala-L-Asp(OMe)-CH2F;AKOS024456966;z-Val-Ala-Asp(OMe) fluoromethylketone;CCG-207882;CS-3153;IDI1_002226;z-Val-Ala-Asp(OMe)-fluoromethyl-ketone;Cbz-Val-Ala-Asp(OMe)-fluoromethylketone;NCGC00163487-01;NCGC00163487-02;AS-74918;Cbz-Val-Ala-Asp(OMe)-fluoromethyl ketone;HY-16658;Z-Val-Ala-Asp(OCH3)-fluoromethyl ketone;z-Val-Ala-Asp(O-methyl)-fluoromethylketone;SW219162-1;Caspase Inhibitor I - CAS 187389-52-2;Z-VAD(OMe)-FMK; Z-Val-Ala-Asp(OMe)-FMK;benzyloxycarbonyl-Val-Ala-Asp(OMe) fluoromethyl ketone;benzyloxycarbonyl-Val-Ala-Asp(OMe)fluoromethyl ketone;N-benzyloxycarbonyl-Val-Ala-Asp(OMe)fluoromethylketone;benzyloxycarbonyl-Val-Ala-Asp(O-Me) fluoromethyl ketone;N-benzyloxycarbonyl-Val-Ala-Asp(OMe) fluoromethyl ketone;N-benzyloxycarbonyl-Val-Ala-Asp(OMe) fluoromethylketone;N-benzyloxycarbonyl-Val-Ala-Asp(OMe)fluoromethyl ketone;benzyloxycarbonyl-Val-Ala-Asp(O-methyl)-fluoromethylketone;N-benzyloxycarbonyl-Val-Ala-Asp(O-methyl) fluoromethyl ketone;N-benzyloxycarbonyl-Val-Ala-Asp(O-methyl)-fluoromethyl ketone;N-benzyloxycarbonyl-Val-Ala-Asp(O-methyl)-fluoromethylketone;(5S,8S,11S)-Methyl 11-(2-fluoroacetyl)-5-isopropyl-8-methyl-3,6,9-trioxo-1-phenyl-2-oxa-4,7,10-triazatridecan-13-oate;L-Alaninamide, N-[(phenylmethoxy)carbonyl]-L-valyl-N-[(1S)-3-fluoro-1-(2-methoxy-2-oxoethyl)-2-oxopropyl]- (9CI);N-[(benzyloxy)carbonyl]-L-valyl-N-[(3S)-5-fluoro-1-methoxy-1,4-dioxopentan-3-yl]-L-alaninamide; |
M.F/Formula | C22H30FN3O7 |
M.W/Mr. | 467.5 |
Sequence | One Letter Code:VAX Three Letter Code:Cbz-Val-Ala-Asp(OMe)-CH2F |
Labeling Target | Pan-caspase |
Application | Z-VAD-FMK is an irreversible, cell-permeable, broad-spectrum caspase inhibitor. |
Appearance | White solid |
Purity | >98.0% |
Activity | Inhibitor |
Areas of Interest | Cancer |
Source# | Synthetic |
Long-term Storage Conditions | Soluble in DMSO |
Shipping Condition | Room temperature in continental US; may vary elsewhere. |
Solubility | -20 °C |
InChI | InChI=1S/C22H30FN3O7/c1-13(2)19(26-22(31)33-12-15-8-6-5-7-9-15)21(30)24-14(3)20(29)25-16(17(27)11-23)10-18(28)32-4/h5-9,13-14,16,19H,10-12H2,1-4H3,(H,24,30)(H,25,29)(H,26,31)/t14-,16-,19-/m0/s1 |
InChI Key | MIFGOLAMNLSLGH-QOKNQOGYSA-N |
Isomeric SMILES | C[C@@H](C(=O)N[C@@H](CC(=O)OC)C(=O)CF)NC(=O)[C@H](C(C)C)NC(=O)OCC1=CC=CC=C1 |
BoilingPoint | 732.4±60.0 °C at 760 mmHg |
Melting Point | N/A |
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com